Table 1 Characteristics of patients included in the immunohistochemistry study
From: Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain
Variables | AD (n = 25) |
|---|---|
Age at death (years) | |
Median [IQR] | 81.0 [73.0–87.0] |
Range | 59.0–96.0 |
Female gender, n (%) | 18 (72) |
Post mosterm interval | |
Median [IQR] | 21.0 [9.0–27.0] |
Range | 3.0–96.0 |
“A” Thal - n of patients (%) | |
3 (4 and 5) | 21 (84) |
2 (3) | 3 (12) |
1 (1 and 2) | 1 (4) |
0 (None) | 0 (0) |
“B” Braak Stage - n of patients (%) | |
3 (V and VI) | 24 (96) |
2 (III and IV) | 1 (4) |
1 (I and II) | 0 (0) |
0 (None) | 0 (0) |